These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1318572

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Staging techniques for lung cancer.
    Lau CL, Harpole DH, Patz E.
    Chest Surg Clin N Am; 2000 Nov; 10(4):781-801. PubMed ID: 11091926
    [Abstract] [Full Text] [Related]

  • 4. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
    Garland L, Robinson LA, Wagner H.
    Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
    [Abstract] [Full Text] [Related]

  • 5. [Value of mediastinoscopy in the preoperative evaluation of non-small cell lung cancer].
    Brichon PY, Latreille R.
    Rev Pneumol Clin; 1992 Feb; 48(5):191-5. PubMed ID: 1338935
    [Abstract] [Full Text] [Related]

  • 6. [Which initial evaluation for non-small-cell bronchial cancers?].
    Milleron B.
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S120-1. PubMed ID: 10088279
    [No Abstract] [Full Text] [Related]

  • 7. Thoracoscopic staging of IIIB non-small cell lung cancer before neoadjuvant therapy.
    De Giacomo T, Rendina EA, Venuta F, Della Rocca G, Ricci C.
    Ann Thorac Surg; 1997 Nov; 64(5):1409-11. PubMed ID: 9386712
    [Abstract] [Full Text] [Related]

  • 8. [Non-small-cell bronchial cancer: update in 1998].
    Mornex F.
    Cancer Radiother; 1998 Nov; 2(5):566-7. PubMed ID: 9868401
    [No Abstract] [Full Text] [Related]

  • 9. [Comments on the guidelines of the French-Language Society of Pneumology on the use of serum tumor markers in the management of primary bronchial cancers. Restatement].
    Roche N, Lioté H, Housset B.
    Rev Mal Respir; 1999 Dec; 16(6):1165-6. PubMed ID: 10637920
    [No Abstract] [Full Text] [Related]

  • 10. Stage IIIB non-small-cell lung cancer.
    Rendina EA, Venuta F, De Giacomo T, Furio Coloni G.
    Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society.
    Am J Respir Crit Care Med; 1997 Jul; 156(1):320-32. PubMed ID: 9230769
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Diagnosis and treatment of N2 lung carcinoma].
    Hu HC, Guo ZF.
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):42-5. PubMed ID: 2848636
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Evaluation of mediastinal lymphatic involvement].
    Depierre A.
    Rev Mal Respir; 1992 Feb; 9 Suppl 4():R273-5. PubMed ID: 1336872
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Diagnostic strategy and treatment planning in bronchial cancer].
    Drings P.
    Radiologe; 1990 Apr; 30(4):149-54. PubMed ID: 2160669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.